Regulatory and Economic Challenges for Gene Therapy Utilization

• 17 April 2018
• By Vidya Narayanaswami, PhD Dr. Stephen F. Amato 

This article addresses pricing and reimbursement challenges associated with clinical utilization of approved gene therapies. The authors recommend potential approaches to resolve these challenges, the implementation of which may help solve issues related to the high cost of these therapies and encourage continued innovation and further development of advanced gene therapies.